Cincinnati Children’s
Cincinnati Children's Hospital Medical Center is a nonprofit pediatric academic medical center founded in 1883 in Cincinnati, Ohio, with 10,000+ employees delivering comprehensive clinical care, NIH-funded research (#3 nationally among children's hospitals), gene and cell therapy manufacturing, AI-enabled healthcare tools, and rare disease network coordination across global clinical sites.
- Company typePrivate
- Founded1883
- HeadquartersCincinnati, United States
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingServices
What Cincinnati Children’s does
Cincinnati Children's Hospital Medical Center is a nonprofit pediatric academic medical center founded in 1883 and headquartered at 3333 Burnet Avenue in Cincinnati, Ohio, with 10,000+ employees across multiple campuses (Burnet, Liberty), urgent care locations, neighborhood primary care sites, and the Uptown research campus. It delivers comprehensive pediatric clinical care from primary care through complex specialty and surgical services, augmented by a 24/7 virtual urgent care platform (CincyKids Health Connect), an EPIC-based MyChart patient portal, and an international patient services program.
The institution's technology and research portfolio spans organoid medicine, gene and cell therapy manufacturing (a four-times-expanded Applied Gene and Cell Therapy Center), advanced imaging (spinout Eyas Medical Imaging's FDA-cleared Ascent3T neonatal 3T MRI, plus the GE HealthCare SIGNA Premier–equipped Imaging R&D Center opened in 2026), and AI-driven clinical and operational tools co-developed with Hippocratic AI and others. It ranks #3 nationally for NIH research funding among children's hospitals, coordinates the Rare Diseases Clinical Research Network DMCC across 19 consortia and 300+ clinical sites, and operates 49 research institutes and divisions producing 4,000+ publications annually (15% YoY growth).
Revenue mechanics combine clinical service billing (insurance, Medicaid, Medicare, self-pay) across inpatient, outpatient, emergency, and urgent care; external research grants from NIH, NCATS, ARPA-H, ARIA, and private foundations ($239 million in FY2025); philanthropy and corporate donations; and licensing/industry partnerships including CAR-T manufacturing for Tempest Therapeutics and BioOra, joint operating agreements with Parkview Health and MultiCare Mary Bridge Children's, and a 12-site international autism research consortium (IMPACT). Customer segments include pediatric patients and families (primary), referring physicians and health systems, the research community, and international patients, with Steve Davis serving as President and CEO.
Cincinnati Children’s firmographics
Firmographics- Name
- Cincinnati Children’s
- Legal name
- Cincinnati Children's Hospital Medical Center
- Website
- https://cincinnatichildrens.org
- Company type
- Private
- Founded year
- 1883
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Cincinnati Children's Hospital Medical Center is a nonprofit pediatric academic medical center founded in 1883 in Cincinnati, Ohio, with 10,000+ employees delivering comprehensive clinical care, NIH-funded research (#3 nationally among children's hospitals), gene and cell therapy manufacturing, AI-enabled healthcare tools, and rare disease network coordination across global clinical sites.
- Ownership category
- akta.pro rank
Cincinnati Children’s industry classification
Industry- Product category
- Pediatric Hospital Services
- SIC
- Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Children’s Hospitals & Pediatric Health Systems (HLAFAJAG)
- akta.pro secondary industries
- Children’s Hospitals (Acute Care) (HLAFAAAI), Pediatric Urgent Care Centers (HLAFADAF), Pediatric Specialty Care Centers (e.g., cardiology, oncology, neurology) (HLAFAJAH)
Keywords
Where Cincinnati Children’s is headquartered
LocationHeadquarters
- HQ city
- Cincinnati
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Cincinnati Children’s business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Clinical Care Services: Patient care services billed through insurance, Medicaid, and self-pay including inpatient, outpatient, emergency, and urgent care services across multiple specialties
- Research Grants and Funding: External research funding from NIH, foundations, and government grants supporting clinical trials and scientific research programs across 49 institutes and divisions
- Philanthropy and Donations: Charitable donations from individuals, corporations, and foundations supporting hospital programs, research, and facilities
Go-to-market motion1 record
Distribution channels6 records
Marketing channels7 records
Cincinnati Children’s product offering
Product offeringCore offering
Cincinnati Children's Hospital Medical Center is a nonprofit pediatric academic medical center providing comprehensive inpatient, outpatient, emergency, urgent, primary, and specialty clinical care for children from birth through young adulthood across its Burnet Campus, Liberty Campus, neighborhood primary care sites, urgent care locations, and telehealth services. It runs a large-scale research enterprise (49 institutes and divisions, $239 million in FY2025 external funding, over 4,000 publications) that produces proprietary gene/cell therapies, organoid platforms, MRI innovations, and AI-enabled clinical tools, and supports a global rare disease data coordinating center across 300+ clinical sites.
Product overview
Cincinnati Children's Hospital Medical Center operates as a comprehensive pediatric academic medical center offering clinical care, research, and education. The organization's product portfolio includes specialized therapeutic manufacturing facilities (Applied Gene and Cell Therapy Center for gene/cell therapies), advanced imaging technology (Ascent3T Neonatal MRI System developed from internal research, Imaging Research & Development Center), AI-powered healthcare tools (Hippocratic AI voice products co-developed for patient and nurse workflows), clinical research programs (food allergy research consortium, rare diseases network, autism IMPACT network), patient-facing digital services (MyChart portal), and drug safety research platforms (CATALYST). The institution's offerings span from direct patient care services to advanced therapeutic development and medical technology innovation.
Differentiator
Problem solved
Functional benefit
Brands
- Eyas Medical Imaging: A startup spun out from Cincinnati Children's Hospital that received FDA 510(k) clearance for the Ascent3T Neonatal MRI System - the first high-field 3 Tesla MRI scanner designed specifically for infants for use in NICUs.
- CincyKids Health Connect
Products and services
- Pediatric Specialty Clinical Care
- Pediatric Urgent Care Services
- CincyKids Health Connect Virtual Urgent Care
- International Patient Services
- MyChart Patient Portal
- Applied Gene and Cell Therapy Center (AGCTC)
- Ascent3T Neonatal MRI System
- Imaging Research & Development Center
- Hippocratic AI Voice AI Products (AI Front Door, Nurse Co-Pilot)
- Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network
- Consortium of Food Allergy Research Clinical Center
- IMPACT Network Autism Research Program
- CATALYST Drug Safety Testing Platform
- Online Second Opinion Service
Quantifiable outcome
- $610,000 in cost savings through expanded telehealth services
- +2 more outcomes
Companies that use Cincinnati Children’s
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Cincinnati Children’s technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability11 records
Feature4 records
Cincinnati Children’s partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core.
- Constantiam BiosciencescoreStrategic collaboration through exclusive option for future licensing rights to advance first-in-class small-molecule treatments for neuronopathic Gaucher disease (Types 2 and 3). Combines Cincinnati Children's validated preclinical data with Constantiam's RareScan functional genomics platform to match therapeutic candidates to responsive patient genotypes across hundreds of GBA1 mutations.
- Parkview HealthcoreFinalized joint operating agreement to expand access to world-class pediatric healthcare for children in Fort Wayne, Indiana and surrounding northern Indiana/northwest Ohio region. Integrates Parkview's pediatric services with Cincinnati Children's expertise, reducing patient transfers and travel burdens. Includes dedicated pediatric emergency department planned for 2027.
- Spinogenixcore$17.25 million, five-year ARIA grant awarded to Cincinnati Children's with Spinogenix Chief Medical Advisor Dr. Craig Erickson as principal investigator. Studying EEG biomarkers combined with genomic analysis to guide precision medicines for autism within the IMPACT network, a 10-site international research consortium.
- GE HealthCare, University of Cincinnati, UC HealthcoreJointly opened the Imaging Research & Development Center on UC's medical campus on May 27, 2026. The center aims to accelerate MRI technology development, improve patient outcomes, and support clinical research with a focus on advanced MRI hardware, software, and imaging techniques. Equipped with GE HealthCare SIGNA Premier 3T wide-bore MRI scanner.
- Hippocratic AIcoreCo-development partner for Nurse Co-Pilot, the first AI voice assistant specifically designed for inpatient nurses. Co-developed alongside OhioHealth and Cleveland Clinic. Nurse Co-Pilot automates admission education, discharge preparation, and medication adherence tasks, potentially returning 1-4 hours per shift to each nurse. Already deployed at Cincinnati Children's.
- BioOra LimitedcoreStrategic partnership to advance Atla-cel, a third-generation CD19-directed CAR-T cell therapy, into clinical development for children with relapsed or refractory B-cell acute lymphoblastic leukaemia. Cincinnati Children's will lead a global clinical program enrolling patients across the United States and New Zealand. Reduced neurotoxicity demonstrated in adult Phase 1 trials.
- Tempest TherapeuticscoreSelected Cincinnati Children's Applied Gene and Cell Therapy Center (AGCTC) as lead contract development and manufacturing partner for TPST-2003, a dual-targeting CD19/BCMA CAR-T therapy for relapsed/refractory multiple myeloma. AGCTC selected as lead manufacturing partner following positive interim data showing 100% complete response in trials.
- MultiCare Mary Bridge Children'scoreCollaboration to expand pediatric heart care and complex surgery access in the Pacific Northwest. Partnership aims to enhance local care with Cincinnati's national expertise including faculty recruitment, joint decision-making, and quality improvement initiatives. New Mary Bridge Children's Hospital tower opening spring 2026.
- Inductive BiocoreParticipating in $21 million ARPA-H funded DATAMAP project to develop AI drug toxicity prediction models using human-based biological data. Collaboration includes Baylor College of Medicine, Amgen, Torch Bio, with focus on cardiotoxicity and drug-induced liver injury. Part of CATALYST initiative to enhance drug safety testing.
- NIH Consortium of Food Allergy ResearchcoreCincinnati Children's awarded NIH grant to join the Consortium of Food Allergy Research as clinical research center, the only such center in Ohio, Kentucky, and Indiana, and one of ten in the US. $380,000 annually for seven years supporting multiple research projects for food allergy understanding and treatment.
Scale indicators7 records
Recent moves8 records
Expansion highlights8 records
Cincinnati Children’s competitors and assessment
Company assessmentDirect peers
- Boston Children's Hospital: Harvard-affiliated pediatric academic medical center consistently ranked #1 or #2 on U.S. News Honor Roll. Direct competitor for complex pediatric referrals, NIH funding, specialty talent, and clinical trial enrollment across all pediatric subspecialties.
- Children's Hospital of Philadelphia (CHOP): Top-ranked pediatric academic medical center and consistent Honor Roll leader. Competes head-to-head with Cincinnati Children's for NIH funding, gene and cell therapy research prominence, and complex specialty referrals.
- Texas Children's Hospital: Baylor-affiliated large pediatric academic medical center ranked among the top Honor Roll hospitals. Comparable in scale (10,000+ employees), research output, and broad specialty depth, with a similar mix of clinical care, research, and education.
- Children's Healthcare of Atlanta: Emory-affiliated pediatric system with strong research enterprise and consistent Honor Roll ranking. Directly comparable as a multi-campus pediatric academic medical center with a major research institute structure.
- Nationwide Children's Hospital: Ohio-based peer pediatric academic medical center and direct geographic competitor for patient referrals and pediatric workforce. Similar scale, research mission, and NIH funding profile, making it a close Midwest comparable.
- Children's Hospital Los Angeles (CHLA): USC-affiliated pediatric academic medical center on the U.S. News Honor Roll. Comparable in research output, specialty breadth, and academic affiliations, and competes with Cincinnati Children's for NIH grants and complex care referrals.
- Ann & Robert H. Lurie Children's Hospital of Chicago: Northwestern-affiliated pediatric academic medical center consistently on the Honor Roll. Comparable as a multi-specialty research-driven children's hospital competing for NIH funding and complex case referrals in the Midwest.
- Lucile Packard Children's Hospital Stanford: Stanford-affiliated pediatric academic medical center with strong research enterprise. Comparable in advanced pediatric specialty offerings and AI/innovation focus, competing for NIH funding and complex referrals.
- Children's National Hospital: George Washington-affiliated pediatric academic medical center in Washington, D.C., consistently ranked on the Honor Roll. Comparable in research intensity, NIH funding profile, and breadth of pediatric specialty services.
- Seattle Children's Hospital: UW-affiliated pediatric academic medical center with significant research enterprise and consistent Honor Roll ranking. Comparable in scale, research output, and as a regional pediatric referral hub competing for NIH dollars.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Cincinnati Children’s social profiles
Digital presenceCincinnati Children’s compliance and trust
Trust signalCompliance7 records
Cincinnati Children’s financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cincinnati Children’s leadership team
Management profileNumber of profiles
Profiles5 records
Cincinnati Children’s subsidiaries and ownership
Company hierarchySubsidiaries1 record
Cincinnati Children’s funding detail
Funding detailFunding overview
Funding rounds6 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cincinnati Children’s M&A and investment
M&A and investmentM&A
Investments15 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cincinnati Children’s
What does Cincinnati Children’s do?
Cincinnati Children's Hospital Medical Center is a nonprofit pediatric academic medical center providing comprehensive inpatient, outpatient, emergency, urgent, primary, and specialty clinical care for children from birth through young adulthood across its Burnet Campus, Liberty Campus, neighborhood primary care sites, urgent care locations, and telehealth services. It runs a large-scale research enterprise (49 institutes and divisions, $239 million in FY2025 external funding, over 4,000 publications) that produces proprietary gene/cell therapies, organoid platforms, MRI innovations, and AI-enabled clinical tools, and supports a global rare disease data coordinating center across 300+ clinical sites.
Is Cincinnati Children’s a public or private company?
Cincinnati Children’s is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Cincinnati Children’s founded?
Cincinnati Children’s was founded in 1883. It employs 5,001 to 10,000 people.
Where is Cincinnati Children’s based?
Cincinnati Children’s is headquartered in Cincinnati, United States, in the North America region.
How does Cincinnati Children’s make money?
Three revenue lines are on record. Clinical Care Services are the primary driver. The others are research Grants and Funding and philanthropy and Donations.
Who are Cincinnati Children’s's main competitors?
Direct peers on record are Boston Children's Hospital, Children's Hospital of Philadelphia (CHOP), Texas Children's Hospital, Children's Healthcare of Atlanta, Nationwide Children's Hospital, Children's Hospital Los Angeles (CHLA), Ann & Robert H. Lurie Children's Hospital of Chicago, Lucile Packard Children's Hospital Stanford, Children's National Hospital and Seattle Children's Hospital.
Does Cincinnati Children’s have an API?
No public API is recorded for Cincinnati Children’s.
What industry is Cincinnati Children’s in?
Cincinnati Children’s's product category is Pediatric Hospital Services. Its primary akta.pro industry code is HLAFAJAG, Children’s Hospitals & Pediatric Health Systems, with a secondary code of HLAFAAAI, Children’s Hospitals (Acute Care). Its SIC code is 8060.